A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events
Clinical trial NCT07448038 · RECRUITING
Trial details
- NCT number
- NCT07448038
- Sponsor
- Genentech, Inc.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-05
- Primary completion
- 2028-01-31
- Enrollment
- 162
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.